FDA label
What is Viberzi used for?
Viberzi contains eluxadoline. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “VIBERZI is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Viberzi?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Viberzi, tablet, film coated
Indications and Usage, quoted from the label by Allergan, Inc. (NDA206940). Cross-references to other label sections are left out.
VIBERZI is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D).
Source: DailyMed label, set id 7821bd40-4c84-4984-951b-6436ae20421a, version 28, effective July 16, 2024. NDC 61874-075, one of 2 listings for this product.
Questions
What is Viberzi used for?
The FDA label says: “VIBERZI is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (IBS-D).”
What drug class is Viberzi?
FDA lists eluxadoline in the mu-Opioid Receptor Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.